| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.3 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.088 | 0.3 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.19 | 0.3 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.21 | 0.3 |